1. Home
  2. CPRX vs NTSK Comparison

CPRX vs NTSK Comparison

Compare CPRX & NTSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.49

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Netskope Inc.

NTSK

Netskope Inc.

HOLD

Current Price

$13.28

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPRX
NTSK
Founded
2002
2012
Country
United States
United States
Employees
N/A
3281
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CPRX
NTSK
Price
$31.49
$13.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
17
Target Price
$35.00
$18.19
AVG Volume (30 Days)
2.0M
6.3M
Earning Date
05-11-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
28.24
N/A
EPS
0.50
N/A
Revenue
$119,072,803.00
N/A
Revenue This Year
$9.20
$25.76
Revenue Next Year
$10.51
$22.02
P/E Ratio
$62.98
N/A
Revenue Growth
16.39
N/A
52 Week Low
$19.05
$7.67
52 Week High
$32.56
$24.98

Technical Indicators

Market Signals
Indicator
CPRX
NTSK
Relative Strength Index (RSI) 70.31 66.20
Support Level $31.25 $8.67
Resistance Level $32.56 $16.75
Average True Range (ATR) 0.04 0.91
MACD -0.05 0.32
Stochastic Oscillator 86.96 67.95

Price Performance

Historical Comparison
CPRX
NTSK

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

About NTSK Netskope Inc.

Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.

Share on Social Networks: